The present study indicated ADAM10 expression regulation by AD, CD and m62A, and in AD/ADAM10/LAG3 or CD/ADAM10/LAG3 signaling in cancers, suggesting a potential method for immunotherapy of cancers by targeting ADAM10 using the small molecules AD, CD and m62A. The gene discussed is CTLA4; the disease is Alzheimer disease.